NO996519L - Doseringsformer av sertralin med forsinket frigjøring - Google Patents

Doseringsformer av sertralin med forsinket frigjøring

Info

Publication number
NO996519L
NO996519L NO996519A NO996519A NO996519L NO 996519 L NO996519 L NO 996519L NO 996519 A NO996519 A NO 996519A NO 996519 A NO996519 A NO 996519A NO 996519 L NO996519 L NO 996519L
Authority
NO
Norway
Prior art keywords
dosage forms
delayed release
release sertraline
sertraline
delayed
Prior art date
Application number
NO996519A
Other languages
English (en)
Norwegian (no)
Other versions
NO996519D0 (no
Inventor
William John Curatolo
Hylar Lewis Friedman
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO996519(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO996519D0 publication Critical patent/NO996519D0/no
Publication of NO996519L publication Critical patent/NO996519L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Addiction (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO996519A 1997-07-01 1999-12-28 Doseringsformer av sertralin med forsinket frigjøring NO996519L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5149997P 1997-07-01 1997-07-01
PCT/IB1998/000937 WO1999001122A1 (en) 1997-07-01 1998-06-16 Delayed-release dosage forms of sertraline

Publications (2)

Publication Number Publication Date
NO996519D0 NO996519D0 (no) 1999-12-28
NO996519L true NO996519L (no) 2000-02-29

Family

ID=21971681

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996519A NO996519L (no) 1997-07-01 1999-12-28 Doseringsformer av sertralin med forsinket frigjøring

Country Status (41)

Country Link
EP (1) EP1007024B1 (uk)
JP (1) JP3786715B2 (uk)
KR (1) KR100369698B1 (uk)
CN (4) CN1494899A (uk)
AP (1) AP1199A (uk)
AR (1) AR038394A2 (uk)
AT (1) ATE245415T1 (uk)
AU (1) AU727152B2 (uk)
BG (1) BG64742B1 (uk)
BR (1) BR9809895A (uk)
CA (1) CA2290969C (uk)
DE (1) DE69816624T2 (uk)
DK (1) DK1007024T3 (uk)
DZ (1) DZ2547A1 (uk)
EA (1) EA001906B1 (uk)
ES (1) ES2202858T3 (uk)
GT (1) GT199800091A (uk)
HK (1) HK1027982A1 (uk)
HN (1) HN1998000099A (uk)
HR (1) HRP980376B1 (uk)
HU (1) HUP0301787A3 (uk)
ID (1) ID23187A (uk)
IL (2) IL133081A (uk)
IS (1) IS5267A (uk)
MA (1) MA24585A1 (uk)
NO (1) NO996519L (uk)
NZ (1) NZ501249A (uk)
OA (1) OA11247A (uk)
PA (1) PA8454201A1 (uk)
PE (1) PE84399A1 (uk)
PL (1) PL337799A1 (uk)
PT (1) PT1007024E (uk)
SI (1) SI1007024T1 (uk)
SK (1) SK173299A3 (uk)
TN (1) TNSN98122A1 (uk)
TR (1) TR199903295T2 (uk)
TW (1) TW575437B (uk)
UA (1) UA63953C2 (uk)
UY (1) UY25068A1 (uk)
WO (1) WO1999001122A1 (uk)
ZA (1) ZA985710B (uk)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2348871C (en) 1998-11-02 2009-04-14 John G. Devane Multiparticulate modified release composition
DE60035579T2 (de) * 1999-05-20 2008-04-17 Elan Corp. Plc Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
EP1671628B1 (en) 1999-09-03 2012-10-03 APBI Holdings, LLC Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
KR20030025903A (ko) * 2000-02-10 2003-03-29 비피에스아이 홀딩스, 인코포레이션. 아크릴 장용 코팅 조성물
EP1313473A2 (en) 2000-08-30 2003-05-28 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
JP5328071B2 (ja) * 2001-04-10 2013-10-30 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 時限パルス放出組成物
CA2457385A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
EP2586429A1 (en) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Multi-unit drug delivery device for pulsatile or sustained release
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) * 2021-11-19 2022-07-05 浙江维康药业股份有限公司 一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
EP0357364B1 (en) * 1988-08-30 1993-07-28 E.I. Du Pont De Nemours And Company A process for flash-spinning dry polymeric plexifilamentary film-fibril strands
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
JP3786715B2 (ja) 2006-06-14
HUP0301787A3 (en) 2005-04-28
CN1475208A (zh) 2004-02-18
AP9801278A0 (en) 1998-06-30
KR100369698B1 (ko) 2003-01-30
IL133081A0 (en) 2001-03-19
EP1007024A1 (en) 2000-06-14
CN1151783C (zh) 2004-06-02
IL133081A (en) 2005-09-25
CN1494899A (zh) 2004-05-12
AU7545198A (en) 1999-01-25
OA11247A (en) 2002-11-19
UY25068A1 (es) 2000-12-29
TW575437B (en) 2004-02-11
HUP0301787A2 (hu) 2003-11-28
PT1007024E (pt) 2003-11-28
HRP980376B1 (en) 2002-12-31
EA199900965A1 (ru) 2000-08-28
PE84399A1 (es) 1999-09-11
ID23187A (id) 2000-03-23
KR20010013522A (ko) 2001-02-26
AR038394A2 (es) 2005-01-12
BR9809895A (pt) 2000-08-01
TNSN98122A1 (fr) 2005-03-15
PA8454201A1 (es) 2000-09-29
GT199800091A (es) 1999-12-21
IL152304A0 (en) 2003-05-29
SK173299A3 (en) 2000-11-07
TR199903295T2 (xx) 2000-08-21
ES2202858T3 (es) 2004-04-01
DK1007024T3 (da) 2003-11-17
JP2000513751A (ja) 2000-10-17
WO1999001122A1 (en) 1999-01-14
MA24585A1 (fr) 1998-12-31
DE69816624D1 (de) 2003-08-28
HRP980376A2 (en) 1999-04-30
HK1027982A1 (en) 2001-02-02
ATE245415T1 (de) 2003-08-15
CA2290969C (en) 2004-02-17
NO996519D0 (no) 1999-12-28
ZA985710B (en) 2000-01-10
SI1007024T1 (en) 2003-12-31
AP1199A (en) 2003-08-28
UA63953C2 (uk) 2004-02-16
EA001906B1 (ru) 2001-10-22
CA2290969A1 (en) 1999-01-14
IS5267A (is) 1999-11-23
CN1261273A (zh) 2000-07-26
CN1475209A (zh) 2004-02-18
NZ501249A (en) 2001-06-29
EP1007024B1 (en) 2003-07-23
BG103916A (en) 2000-07-31
PL337799A1 (en) 2000-09-11
BG64742B1 (bg) 2006-02-28
DE69816624T2 (de) 2004-02-19
AU727152B2 (en) 2000-12-07
HN1998000099A (es) 1998-10-22
DZ2547A1 (fr) 2003-02-08

Similar Documents

Publication Publication Date Title
NO996518L (no) Sertralinsalter og doseringsformer av sertralin med vedvarende frigjøring
DK0914119T3 (da) Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan
BR9708585A (pt) Forma de dosagem sólida Ph-independente de liberação imediata da cisaprida
DK0922386T3 (da) Sammensætninger med reguleret frigivelse
DK0682945T3 (da) Oralt præparat med forsinket frigivelse
ATE253371T1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
ID25792A (id) Antibodi-antibodi terhadap cd40 manusia
DK0758244T3 (da) Doseringsformer af azithromycin med styret frigivelse
EE200000383A (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
NO996519L (no) Doseringsformer av sertralin med forsinket frigjøring
NO20002126L (no) Formulering med forlenget frigjøring
DE69518193D1 (de) Präparat mit verzörgerter Wirkstoffabgabe
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
DK0980241T3 (da) Gelatineindkapslede opløsningsdosisformer af sertralin
DE69609897T2 (de) Aromazusammensetzungen mit verzögerter Freigabe
NO991148L (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
ZA985707B (en) Sertraline salts and sustained-release dosage forms of sertraline.
NO971030L (no) Preparat med langvarig frigjöring
PT941075E (pt) Forma de dosagem farmaceutica de libertacao rapida e dissimulada do sabor
FIU990032U0 (fi) Hirsikerautapari
FI980484A0 (fi) Foerfarande foer blaeddring av hypertextssidor med en mobilteleapparat
KR960023593U (ko) 캘리퍼브레이크의 체결구조
SI0980241T1 (en) Gelatine encapsulated solution dosage forms of sertraline
UA34056A (uk) Склад для профілактики алергодерматозів

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application